Author

Sergio Rutella

Nottingham Trent UniversityORCID 0000-0003-1970-7375Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

Jayakumar Narayanan VadakekolathuiD· 2 shared Adam Bills· 1 shared Alexander V. PredeusiD· 1 shared Alison RitchieiD· 1 shared Andrew Silver· 1 shared Batuhan S. Cakir· 1 shared Benjamin DickinsiD· 1 shared Christos PolytarchouiD· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Jayakumar Narayanan VadakekolathuORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologyStem Cell Research & TherapyPeer-reviewedApr 9, 2026

Generation of transplantable and biologically responsive colonic tissue from human induced pluripotent stem cells using a rapid co-differentiation platform.

William Dalleywater, Alexander V. Predeus, Batuhan S. Cakir…·Mohammad Ilyas

This paper develops a co-differentiation platform using human iPSCs to generate transplantable colonic tissue that mimics native mucosa and responds to biological signals.

DOI 10.1186/s13287-026-05006-4

humanbulk RNA-seq

𝕏 PostBluesky

Molecular BiologyJournal of Gastroenterology and HepatologyPeer-reviewedDec 20, 2021

Hyperactive chemotaxis contributes to anti-TNFα treatment resistance in inflammatory bowel disease

Tung On Yau, Jayakumar Narayanan Vadakekolathu, Gemma Ann Foulds…·Sergio Rutella

The paper identifies hyperactive chemotaxis and IL13RA2 as factors contributing to anti-TNFα treatment resistance in IBD.

13 citations

humanbulk RNA-seq

𝕏 PostBluesky